What’s New in Ocular Drug Delivery: Advances in Suprachoroidal Injection since 2023Review Published on 2024-07-302024-09-05 Journal: Pharmaceuticals [Category] update2024, [키워드] choroid Cost-benefit analysis humans Injections Intraocular Quality of life Retinal diseases Treatment outcome visual acuity [DOI] 10.3390/ph17081007 PMC 바로가기 [Article Type] Review
Immunoassay and mass cytometry revealed immunological profiles induced by inactivated BBIBP COVID-19 vaccineArticle Published on 2022-11-012022-11-15 Journal: Journal of medical virology [Category] COVID19(2023년), SARS, 변종, 진단, [키워드] analyzed antibody Antibody titer B cell booster booster dose caused Cell Cluster Concentration conducted COVID-19 COVID-19 vaccine CyTOF Cytometry declined decrease distribution Efficacy ENhance healthy highlight humoral Immune cell immune response Immunity immunization immunoassay immunological profile inactivated individual injection Injections lack maintain marker multicenter neutralizing antibody not significantly different participant prevalence of COVID-19 proportion protective effect recall receiving recruited reduced SARS-CoV-2 second dose serum antibody shown significantly significantly increased Still subject surface marker sVNT the antibody response the vaccine vaccination Vaccine vaccine doses vaccine injection Viral variants virus neutralization test [DOI] 10.1002/jmv.27983 PMC 바로가기
The negative impact of COVID-19 pandemic on age-related macular degeneration patients treated with intravitreal bevacizumab injectionsArticle Published on 2022-11-012022-11-15 Journal: International ophthalmology [Category] 진단, [키워드] adherent Age-related macular degeneration AMD bevacizumab change Clinical outcome Compliance COVID-19 COVID-19 pandemic defined Follow-up implication individual injection Injections intravitreal intravitreal injection lockdown Loss Loss of follow-up. not significant outcome pandemic Patient patients patients treated proportion remained study period subsequent visual acuity worldwide pandemic worsened [DOI] 10.1007/s10792-022-02337-y PMC 바로가기
Post-intravitreal injection endophthalmitis pattern during the COVID-19 pandemic with implementation of patients’ maskingArticle Published on 2022-11-012022-11-15 Journal: Graefe's Archive for Clinical and Experimental Oph [Category] 진단, [키워드] 95% confidence interval Administered Analysis association COVID COVID-19 COVID-19 epidemic COVID-19 pandemic decrease endophthalmitis evaluate eye facial implementation increased risk injection Injections intravitreal injection Iran main outcome measure Mask occurred Occurrence Operating room Patient physician Post-intravitreal injection endophthalmitis. receiving retrospective cohort risk statistically significant the patient was performed [DOI] 10.1007/s00417-022-05726-2 PMC 바로가기
Booster dose of mRNA vaccine augments waning T cell and antibody responses against SARS-CoV-2Article Published on 2022-10-122022-11-16 Journal: Frontiers in Immunology [Category] COVID19(2023년), SARS, 변종, [키워드] activated T cell antibodies antibody Antibody Response booster booster dose booster vaccination CD137 CD69 CD8 T cell Cellular immune response ChAdOx1-S conducted decrease dose expressing expression Frequency humoral IFN-γ immune response immunosuppressive increase in indicated Infection Injections lack longitudinal analysis memory monocyte mRNA mRNA vaccine myeloid cell omicron participant PD-L1 peptides phenotype producing protective immunity reactive reduced SARS-CoV-2 SARS-CoV-2-specific T cell T cell T cell response T cells the spike protein TNF-α upregulation vaccination Vaccinations Vaccine variant vector vaccine virus-specific T cell [DOI] 10.3389/fimmu.2022.1012526 PMC 바로가기
Perspectives of people living with HIV-1 on implementation of long-acting cabotegravir plus rilpivirine in US healthcare settings: results from the CUSTOMIZE hybrid III implementation-effectiveness studyArticle Published on 2022-09-012022-11-15 Journal: Journal of the International AIDS Society [Category] 치료제, [키워드] acceptability Administered African American All participant antiretroviral Antiretroviral therapy appropriateness baseline black conducted COVID-19 pandemic Data collection eight enrolled evaluated healthcare HIV clinics HIV-1 implementation injection Injections integrase strand transfer inhibitor non-nucleoside reverse transcriptase inhibitor Pain participant Patient Perspective PLHIV Quantitative Randomly receive receiving regimen remained reported RNA Satisfaction selected subset suppressed Tablet therapy time total score transcriptase transfer Treatment treatment satisfaction. [DOI] 10.1002/jia2.26006 PMC 바로가기
Tixagevimab and Cilgavimab (Evusheld) boosts antibody levels to SARS-CoV-2 in patients with multiple sclerosis on b-cell depletersTixagevimab 및 Cilgavimab(Evusheld)는 b 세포 고갈자에 대한 다발성 경화증 환자에서 SARS-CoV-2에 대한 항체 수준을 높입니다.Article Published on 2022-07-012022-09-12 Journal: Multiple sclerosis and related disorders [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] Affect All participant antibody Antibody Response Antibody testing baseline boost cilgavimab cohort study COVID-19 COVID-19 vaccine creating demonstrated evaluate Evusheld highest Immunity Injections mRNA vaccination Multiple multiple sclerosis Ocrelizumab Ofatumumab Patient patient population performed protective immune response provide receiving SARS-CoV-2 single-center the antibody response the vaccine therapy Tixagevimab treated USA vaccination were measured [DOI] 10.1016/j.msard.2022.103905 PMC 바로가기 [Article Type] Article
Hemi- and Central Retinal Vein Occlusion Associated with COVID-19 Infection in Young Patients without Known Risk FactorsResearch article Published on 2022-06-012022-10-05 Journal: Ophthalmology. Retina [Category] 바이오마커, 변종, [키워드] age Anti-VEGF association Case series case sery Clinical course Complete Confirmed COVID-19 infection coronavirus disease counting fingers COVID-19 COVID-19 diagnosis COVID-19 infection diabetes edema event exclusion criteria eye Factor Final Follow-up follow-up period Hemi Hospitalization Hospitalized hypercoagulable states hypertension Infection Injections Intubated intubation macular edema measure median median age median time multicenter obesity ocular ophthalmic Patient potential risk presenting raise raised ranged reported Result Retinal vascular disease retinal vein retinal vein occlusion retrospective Symptom thromboembolic complication treated Vascular Venous Thromboembolism visual acuity with COVID-19 [DOI] 10.1016/j.oret.2022.02.004 [Article Type] Research article
Belt and Suspenders: Vaccines and Tixagevimab/Cilgavimab for Prevention of COVID-19 in Immunocompromised Patients벨트 및 멜빵: 면역 저하 환자의 COVID-19 예방을 위한 백신 및 Tixagevimab/CilgavimabEditorial Published on 2022-06-012022-09-12 Journal: Annals of internal medicine [Category] Fulltext, MERS, 진단, [키워드] Administered AstraZeneca COVID-19 drug Emergency use authorization food Injections Intervention Older prevention prevention of COVID-19 [DOI] 10.7326/M22-1026 PMC 바로가기 [Article Type] Editorial
Response to three doses of the Pfizer/BioNTech BNT162b2 COVID-19 vaccine: a retrospective study of a cohort of haemodialysis patients in France화이자/바이오엔텍 BNT162b2 코로나19 백신 3회 투여에 대한 반응: 프랑스 혈액투석 환자 집단에 대한 후향적 연구Observational Study Published on 2022-05-182022-09-12 Journal: BMC Nephrology [Category] COVID19(2023년), MERS, SARS, 임상, 진단, [키워드] Anti-spike blood sample BNT162b2 body mass index booster Clinical practice Cohort Comirnaty coronavirus disease COVID-19 defined dialysis dose Factor France French Haemodialysis humoral humoral immune response identify IgG Immunoglobulin injection Injections kidney mortality rate mRNA vaccine National non-responder of BNT162b2 Patient patients performed Pfizer/BioNTech receive Registered remained Responder response retrospective Retrospective study SARS-CoV-2 serological serum albumin significantly significantly higher study population the mean the median titre U/mL Vaccine vaccine doses venous [DOI] 10.1186/s12882-022-02751-5 PMC 바로가기 [Article Type] Observational Study